Gujarat-based Medicap Medical care submits DRHP with Sebi to elevate Rs 240 crore

Medicap Medical care Limited has actually submitted its Draft False trail Program (DRHP) with market regulatory authority Securities and Exchange Board of India (SEBI) to release its initial public offering (IPO). The company prepares to increase Rs 240 crore by issuance of fresh equity without any sell (OFS) element based on its draft documents.

About the business

Medicap Health care is a popular gamer in the Indian pharmaceutical packaging sector, being experts in the manufacturing of pharmaceutical closures, including Euro Head caps and container preforms. The firm operates from a 6, 732 square meter production facility, situated at Vadodara’s Manjusar. The complete annual mounted capacity of producing approximately 751 million systems– 389 million systems in pharma packaging Euro Head Caps, 149 million units in bottle preforms and 213 million systems in other guard caps. The business created 454 million units in FY 2025

As of FY 25, the firm had a pan-India presence across 21 states and 5 Union territories while its sales existence is throughout 14 nations, the DRHP claimed.

The company’s promoters are Kamalkumar Aggarwal, Rajveer Kamal Aggarwal and Minal Aggarwal.

Medicap Medical care financials

Since FY 2025, the firm’s 80 02 % revenue from procedures originated from residential sales and the equilibrium 19 98 % was from exports to 14 nations. The company has about 1 4 % of the international market share and more than 40 % domestic market share for Euro Head caps, the DRHP stated, pointing out F&S Record.

Medicap Medical care IPO continues

The Gujarat-based firm plans to buy plant & & machinery for its existing manufacturing device, aggregating approximately Rs 74 37 Crore). As much as Rs 32 90 crore from the IPO earnings is anticipated to be made use of for settlement or pre-payment of particular borrowings availed by the business.

In addition, the company will make financial investment in its subsidiary KASR Medical care Private Limited for settlement or pre-payment of fundings amounting as much as Rs 52 80 crore). The equilibrium will be utilised for general corporate functions.

Medicap Healthcare IPO lead supervisors

Aryaman Financial Providers Limited is the single Publication Running Lead Supervisor (BRLM) for the issue.Also Read: NSB BPO Solutions IPO: GMP, cost band among vital information to understand prior to subscription

(Please Note: Recommendations, recommendations, sights and opinions provided by the experts are their very own. These do not represent the sights of the Economic Times)